Estudio descriptivo de casos con muerte relacionado al uso de medicamentos en el año 2016 en Bogotá Colombia

A descriptive analysis was carried out based on the reports presented in the District Pharmacovigilance Program of Bogotá in 2016 with the purpose of establishing the prevalence of adverse and related events in the reported cases of the 254 cases presented by the distribution program of pharmacovigilance, the exclusion of the 8 data that did not belong to the year 2016 and 46 cases in which no death was generated was made, leaving a total of 199 cases, using variables such as: age, sex, type of report (Suspicion a Adverse Reaction a Drug and Problems Related to Drugs), causality, negative reaction to medications, terminology of the adverse reactions of the World Health Organization, International Common Denomination. Of the 199 cases analyzed that have the diseases that most frequently occurred: secondary hyperparathyroidism, lower respiratory tract diseases generated by the respiratory syncytial virus, prostate cancer, mother's cancer and which were distributed 185 cases for SRAM and 12 cases for PRM. The majority of patients are in the range between 70 to 74 years of age, followed by the range of 0 to 4 years, presenting 25 and 24 cases respectively, related to the medications Palivizumab and Paricalcitol, the most frequent alterations. The main indicators were: cardiorespiratory and acute myocardial infarction identified PRMs respond, erroneous administration, quality, errors of prescription, dose guideline and contraindication to 6% of the reports. Most of the suspect drugs with which it was reported, the death corresponds to the innovative medicines, which could be a reflection of the therapeutic follow-up to the patients that are carried out by the holder of the sanitary registry. What is consistent with new medicines and surveillance in their commercialization begins to show trends.

• Autores: Rojas Valero, Isaac; Guerrero Alonso, Mabel Gisella
• Tipo de recurso: Trabajo de grado de pregrado
• Fecha de publicación: 2017
• Institución: Universidad de Ciencias Aplicadas y Ambientales U.D.C.A
• Repositorio: Repositorio Institucional UDCA
• Idioma: spa
• OAI Identifier: oai:repository.udca.edu.co:11158/853
• Acceso en línea: https://repository.udca.edu.co/handle/11158/853
• Palabra clave: Farmacovigilancia; Reacción adeversa a medicamento; Muerte; Farmacovigilancia; Medicamentos -- Efectos secundarios
• Rights: closedAccess
• License: Derechos Reservados - Universidad de Ciencias Aplicadas y Ambientales